Your session is about to expire
← Back to Search
Behavioural Intervention
Telerehabilitation for Stroke
N/A
Recruiting
Led By Natalia Covarrubias-Eckardt, MD
Research Sponsored by TRCare, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 years or older
Stroke that is radiologically verified, due to ischemia or to intracerebral hemorrhage, and with time of stroke onset <30 days prior to enrollment; or traumatic brain injury.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up "baseline" and "immediately after end of treatment"
Awards & highlights
Study Summary
This trial tests if extra rehab therapy, provided in-hospital with a newly developed sensor-based training system, can help improve arm function in stroke patients.
Who is the study for?
This trial is for adults over 18 who've had a stroke within the last 30 days, causing arm weakness but not complete paralysis. They must be able to follow instructions and participate in therapy using their arms, without major neurological or psychiatric conditions that would interfere with the study.Check my eligibility
What is being tested?
The HandyMotion Treatment Program is being tested to see if it's safe and doable for stroke patients. It's a sensor-based system connected to a TV, allowing patients to play rehab games and do exercises from their hospital room anytime during their stay.See study design
What are the potential side effects?
Since this intervention involves physical rehabilitation exercises, potential side effects may include muscle soreness or fatigue due to exercise. There might also be discomfort associated with repetitive movements during recovery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I had a stroke or brain injury less than 30 days ago.
Select...
I have some weakness in one arm but can still move it.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ "for approximately 2 weeks, up until 2 days prior to discharge"
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~"for approximately 2 weeks, up until 2 days prior to discharge"
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Safety of daily beside telerehabilitation based on incidence of treatment-emergent adverse events as assessed by regular review of the medical record and patient interview
Secondary outcome measures
Box and Blocks Test
Feasibility of daily bedside telerehabilitation based on measurement of patient compliance, as determined by reviewing electronic records of device usage
Trial Design
1Treatment groups
Experimental Treatment
Group I: Bedside TelerehabilitationExperimental Treatment1 Intervention
Participants will be assigned 45-minute therapy training exercises each day for 5 days per week.
Participants will use the HandyMotion device to interact with the telerehabilitation program displayed on the TV set in the patient room.
Find a Location
Who is running the clinical trial?
TRCare, Inc.Lead Sponsor
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Stroke
60 Patients Enrolled for Stroke
Providence St. Jude Medical CenterUNKNOWN
Natalia Covarrubias-Eckardt, MDPrincipal InvestigatorProvidence St. Jude Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can move my arms well enough to do therapy.I am 18 years old or older.I had a stroke or brain injury less than 30 days ago.I think my mental ability may prevent me from following game or exercise instructions.My best eye sees worse than 20/50, even with glasses or contacts.I have some weakness in one arm but can still move it.I do not have a severe brain condition like advanced dementia.My shoulder pain may limit my ability to complete online rehab therapy.
Research Study Groups:
This trial has the following groups:- Group 1: Bedside Telerehabilitation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still chances for participants to join this clinical trial?
"According to clinicaltrials.gov, the recruitment phase of this trial has ended - it was first posted on December 1st 2022 and last updated 18th November 20202. Despite not actively seeking new patients, 1043 other studies are still recruiting individuals for their research initiatives."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger